Q32 Bio Inc. Common Stock (QTTB) is a publicly traded Healthcare sector company. As of May 21, 2026, QTTB trades at $5.61 with a market cap of $97.50M and a P/E ratio of 2.04. QTTB moved -6.43% today. Year to date, QTTB is +68.25%; over the trailing twelve months it is +220.34%. Its 52-week range spans $1.35 to $53.17. Analyst consensus is buy with an average price target of $14.33. Rallies surfaces QTTB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Q32 Bio Inc. Common Stock (QTTB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. QTTB moved -6.43% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $5.61 |
| Market Cap | $97.50M |
| P/E Ratio | 2.04 |
| EPS | $2.79 |
| Dividend Yield | 0.00% |
| 52-Week High | $53.17 |
| 52-Week Low | $1.35 |
| Volume | 122 |
| Avg Volume | 0 |
| Revenue (TTM) | $53.92M |
| Net Income | $33.24M |
| Gross Margin | 0.00% |
3 analysts cover QTTB: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.33.